AG 1517

EGFR kinase inhibitor

Catalog No. SIH-427

0 out of 5 based on 0 customer ratings
CAS No. 153436-54-5
Molecular Formula C16H14BrN3O2
SKU: SIH-427 Categories: ,

Clear
SIH-427_AG_1517_Chemical_Structure.png
Product Name AG 1517
Description

EGFR kinase inhibitor

Purity >98% (TLC)
CAS No. 153436-54-5
Molecular Formula C16H14BrN3O2
Molecular Weight 360.2
Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

Properties

Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO
Source Synthetic
Appearance White to off-white solid
SMILES COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=CC=C3)Br)OC.Cl
InChI InChI=1S/C16H14BrN3O2/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11/h3-9H,1-2H3,(H,18,19,20)
InChIKey LSPANGZZENHZNJ-UHFFFAOYSA-N
Safety Phrases Classification:
Acute toxicity, Oral (Category 3)
Skin irritation (Category 2)
Serious eye damage (Category 1)
Specific target organ toxicity-single exposure (Category 3)

Safety Phrases:
S22 - Do not breathe dust.
S24/25 - Avoid contact with skin and eyes.
S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection.

Hazard statements:
H301 Toxic if swallowed.
H315 Causes skin irritation.
H318 Causes serious eye damage.
H335 May cause respiratory irritation

Precautionary statements:
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray.
P280 Wear protective gloves/ eye protection/ face protection.
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/ physician.
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Cite This Product AG 1517 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-427)

Biological Description

Alternative Names 4-[(3-Bromophenyl)amino]-6,7-dimethoxyquinazoline hydrochloride, AG 1517, PD 153035, SU 5271, ZM 252868, PD 153,035, SU 5271, 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline
Research Areas Apoptosis, Cancer, Cancer Growth Inhibitors, Cell Signaling, Tyrosine Kinase Inhibitors
PubChem ID 4705
Scientific Background AG 1517 is a potent and selective ATP-competitive inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. EGFR signaling plays a critical role in regulating cell proliferation, survival, and differentiation, and its dysregulation has been implicated in various pathological conditions, including cancer and neurodegeneration.

In the context of neuroscience, EGFR is increasingly recognized for its involvement in neuroinflammatory responses, glial cell activation, and neuronal survival. Overactivation of EGFR pathways has been linked to oxidative stress and excitotoxicity—key contributors to the progression of neurodegenerative diseases such as Alzheimer’s and Parkinson’s. By selectively inhibiting EGFR, AG 1517 offers a targeted approach to modulating these detrimental signaling cascades.

Moreover, EGFR inhibition may influence neurogenesis and synaptic plasticity, processes essential for cognitive function and brain repair. AG 1517’s cell-permeable nature enhances its utility in both in vitro and in vivo models, making it a valuable tool for dissecting EGFR-mediated mechanisms in the central nervous system.

While originally developed for oncology, AG 1517 is gaining traction in neurobiology as a candidate for exploring therapeutic strategies aimed at reducing neuroinflammation, promoting neuronal resilience, and mitigating the molecular drivers of neurodegeneration.
References 1. Kunkel M.W., et al. (1996) Investigational New Drugs. 13(4): 295–302.

Product Images

<p>Chemical structure of AG 1517 (SIH-427), a EGFR tyrosine kinase inhibitor. CAS #: 153436-54-5. Molecular Formula: C16H14BrN3O2. Molecular Weight: 360.2 g/mol.</p>

Chemical structure of AG 1517 (SIH-427), a EGFR tyrosine kinase inhibitor. CAS #: 153436-54-5. Molecular Formula: C16H14BrN3O2. Molecular Weight: 360.2 g/mol.

Reviews

Reviews

There are no reviews yet.

Be the first to review “AG 1517”

Your email address will not be published. Required fields are marked *